Independent Director 2025 Annual Performance Report (He Qing)

Independent Director 2025 Annual Performance Report

He Qing

Dear Shareholders and Shareholder Representatives:

I, He Qing, as an independent director of Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (hereinafter referred to as the "Company"), strictly abide by the "Company Law of the People's Republic of China," "Guidelines on Corporate Governance for Listed Companies," and the "Administrative Measures for Independent Directors of Listed Companies," as well as the "Articles of Association" and other laws and regulations. With the principles of objectivity, fairness, and independence, I have diligently performed my duties, actively exercised my role as an independent director, and protected the overall interests of the Company and the legitimate rights and interests of all shareholders, especially small and medium shareholders. After the election of the sixth board of directors on May 15, 2025, I assumed the position of an independent director. The following is a summary of my performance during the 2025 term:

I. Basic Information of Independent Director

(I) Work Experience, Professional Background, and Concurrent Positions of Independent Director

I, He Qing, born in 1974, am a Chinese national with no permanent overseas residency, holding a Master's degree. I am a Certified Public Accountant (CPA) in China and hold an ACCA qualification from the UK. I have experience in real estate valuation, auditing at accounting firms, accounting in industrial companies, financing for group settlement centers, corporate equity financing, and New Third Board listings. Since 2012, I have been engaged in private equity fund management, serving successively as Senior Vice President of Shenzhen United Investment Management Co., Ltd., Investment Director and Deputy General Manager of Shenzhen Special Investment Co., Ltd., Investment Director and Deputy General Manager of Special Rich Sea Equity Investment Fund Management (Shenzhen) Co., Ltd. Currently, I am a Senior Partner at Wuhu Laixing Investment Partnership (Limited Partnership). I also serve as an independent director for Shenzhen Meilian Medical Electronics Co., Ltd. (New Third Board listed company 833505) and Shenzhen Hannuo Medical Technology Co., Ltd. (proposed listing). Since May 2025, I have served as an independent director of the Company.

(II) Statement of Independence

During my tenure as an independent director of the Company, I have not held any positions in the Company other than that of an independent director, nor have I held any positions in the main shareholder companies. There are no relationships between me, the Company, and its major shareholders that would hinder my independent and objective judgment. There are no circumstances that affect the independence of an independent director, which complies with the "Administrative Measures for Independent Directors of Listed Companies," the "Shenzhen Stock Exchange Listed Company Self-Regulatory Guidelines No. 2 - Norms for the Operation of GEM Listed Companies," and other relevant laws, regulations, normative documents, and the "Articles of Association" and the "Independent Director Work System" regarding the independence of independent directors.

II. Annual Performance of Independent Director

(I) Attendance at Board of Directors and Shareholders' (General) Meetings

During the 2025 term, the Company held 3 board meetings and 1 shareholders' (general) meeting. As an independent director of the Company, I personally attended all board meetings held during my term, diligently performed my duties as an independent director, and exercised my voting rights. I did not miss any meetings, entrust others to attend on my behalf, or fail to attend in person for two consecutive meetings.

The following is a summary of my attendance at board and shareholders' (general) meetings in 2025: